Back
Karyopharm Therapeutics Stock Predictions
Major Market Shift - Act Now Before it's Too Late
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
44
KPTI
Karyopharm Therapeutics
Last Price:
$5.59
Seasonality Move:
-8.13%
7 Day Trial
ALL ACCESS PASS
$
7
Market's down 10% YTD Buffet's Berkshire up 13%
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Karyopharm Therapeutics Stock Forecast
-
Over the next 52 weeks, Karyopharm Therapeutics has on average historically fallen by 3.7% based on the past 11 years of stock performance.
-
Karyopharm Therapeutics has fallen lower in 7 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.64%
-
Is Karyopharm Therapeutics Stock Undervalued?The current Karyopharm Therapeutics [KPTI] share price is $5.97. The Score for KPTI is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
KPTI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Karyopharm Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Karyopharm Therapeutics has on average historically fallen by 3.7% based on the past 11 years of stock performance.
Karyopharm Therapeutics Stock Rating
Sell
44
Karyopharm Therapeutics (KPTI)
is a Sell
Is Karyopharm Therapeutics overpriced?
-
Karyopharm Therapeutics has fallen lower in 7 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.64%
Karyopharm Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
karyopharm.com
52-Week Data
52-Week High:
18.00
52-Week Low:
3.51
Prediction Charts
Market Cap:
50.2M
Price in USD:
5.97
Volume:
115.9K
Beta:
0.96
Technical Analysis
SMA50:
6.31
SMA100:
8.43
SMA200:
10.51
52-Wk Change:
-63.49%
Stock Predictions
-
Is Karyopharm Therapeutics stock public?Yes, Karyopharm Therapeutics is a publicly traded company.
-
What is the Karyopharm Therapeutics stock quote today?The Karyopharm Therapeutics stock price is 5.97 USD today.
-
How to buy Karyopharm Therapeutics stock online?You can buy Karyopharm Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Apr-4 | 3.74 | 3.86 | 3.89 | 3.51 |
| Apr-7 | 3.68 | 4.04 | 4.10 | 3.56 |
| Apr-8 | 4.24 | 3.96 | 4.36 | 3.91 |
| Apr-9 | 3.91 | 4.23 | 4.33 | 3.83 |
| Apr-10 | 4.11 | 3.99 | 4.30 | 3.83 |
| Apr-11 | 3.97 | 4.29 | 4.29 | 3.86 |
| Apr-14 | 4.35 | 4.21 | 4.35 | 4.03 |
| Apr-15 | 4.22 | 4.26 | 4.37 | 4.22 |
| Apr-16 | 4.30 | 4.42 | 4.54 | 4.24 |
| Apr-17 | 4.37 | 4.95 | 5.08 | 4.37 |
| Apr-21 | 4.89 | 5.40 | 5.50 | 4.89 |
| Apr-22 | 5.47 | 6.03 | 6.08 | 5.39 |
| Apr-23 | 6.17 | 6.27 | 6.56 | 6.09 |
| Apr-24 | 6.28 | 5.97 | 6.46 | 5.78 |
Karyopharm Therapeutics Earnings
Karyopharm Therapeutics Earnings Report: Per Share Karyopharm Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Karyopharm Therapeutics Forecast Revenue Growth
Karyopharm Therapeutics Stock Analysis: Historical quarterly revenues per share for Karyopharm Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $1.00 per share, a decrease next quarter of $2.05 per share, a decrease this year of $1.95 per share, and an increase next year of $2.97 per share.
* Karyopharm Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.